A shared parameter model of longitudinal measurements and survival time with heterogeneous random-effects distribution

References

• M. Aitkin and D.B. Rubin, Estimation and hypothesis testing in finite mixture models, J. Soc., Ser. B 47 (1985), pp. 67–75.
   Web of Science ®Google Scholar
• T. Baghfalaki, M. Ganjali, and D. Berridge, Robust joint modeling of longitudinal measurements and time to event data using normal/independent distributions: A Bayesian approach, Biometr. J. 55 (2013), pp. 844–865. doi: 10.1002/bimj.201200272
   PubMed Web of Science ®Google Scholar
• T. Baghfalaki, M. Ganjali, and D. Berridge, Joint modeling of multivariate longitudinal mixed measurements and time to event data using a Bayesian approach, J. Appl. Stat. 41 (2014), pp. 1934–1955. doi: 10.1080/02664763.2014.898132
   Web of Science ®Google Scholar
• T. Baghfalaki, M. Ganjali, and R. Hashemi, Bayesian joint modeling of longitudinal measurements and time-to -event data using robust distributions, J. Biopharm. Stat. 24 (2014), pp. 834–855. doi: 10.1080/10543406.2014.903657
   PubMed Web of Science ®Google Scholar
• T. Baghfalaki, S. Sefidi, and M. Ganjali, A semi-parametric approach for analyzing longitudinal measurements with non-ignorable missingness using regression spline, Appl. Appl. Math. 10 (2015), pp. 195–211.
   Google Scholar
• D. Bohning, Computer-Assisted Analysis of Mixtures and Applications: Meta-Analysis, Disease Mapping and Others, Monographs on Statistics and Applied Probability, Vol. 81, Chapman & Hall/CRC, Berlin, 1999.
   Google Scholar
• S.P. Brooks, Discussion on the paper by Spiegelhalter, Best, Carlin and vandeLinde, 2002, J. R. Statist. Soc. Ser. B 64 (2002), pp. 616–618.
   Google Scholar
• S. Cagnone and C. Viroli, A factor mixture analysis model for multivariate binary data, Statist. Model. 12 (2012), pp. 257–277. doi: 10.1177/1471082X1101200303
   Web of Science ®Google Scholar
• P. Carlin and T.A. Louis, Bayes and Empirical Bayes Methods for Data Analysis, 2nd ed., Chapman & Hall CRC Press, New York, 2000.
   Google Scholar
• M.-H. Chen, J.G. Ibrahim, and D. Sinha, A new joint model for longitudinal and survival data with a cure fraction, J. Multivariate Anal. 91 (2004), pp. 18–34. doi: 10.1016/j.jmva.2004.04.005
   Web of Science ®Google Scholar
• Y.-Y. Chi and J.G. Ibrahim, Joint models for multivariate longitudinal and multivariate survival data, Biometrics 62 (2006), pp. 432–445. doi: 10.1111/j.1541-0420.2005.00448.x
   PubMed Web of Science ®Google Scholar
• A. Gelman and D.B. Rubin, Inference from iterative simulation using multiple sequences, Stat. Sci. 7 (1992), pp. 457–472. doi: 10.1214/ss/1177011136
   Google Scholar
• A.I. Goldman, B.P. Carlin, L.R. Crane, C. Launer, J.A. Korvick, L. Deyton, and D.I. Abrams, Response of CD4+ and clinical consequences to treatment using ddI or ddC in patients with advanced HIV infection, J. Acq. Immun. Def. Synd. Human Retrovirol. 11 (1996), pp. 161–169. doi: 10.1097/00042560-199602010-00007
   PubMedGoogle Scholar
• X. Guo and B.P. Carlin, Separate and joint modeling of longitudinal and event time data using standard computer packages, Amer. Statist. 58 (2004), pp. 16–24. doi: 10.1198/0003130042854
   Web of Science ®Google Scholar
• R. Henderson, P. Diggle, and A. Dobson, Joint modelling of longitudinal measurements and event time data, Biostatistics 4 (2000), pp. 465–480. doi: 10.1093/biostatistics/1.4.465
   Google Scholar
• J.W. Hogan and N.M. Laird, Model-based approaches to analysing incomplete longitudinal and failure time data, Stat. Med. 16 (1997), pp. 259–272. doi: 10.1002/(SICI)1097-0258(19970215)16:3<259::AID-SIM484>3.0.CO;2-S
   PubMed Web of Science ®Google Scholar
• X. Huang, G. Li, and R.M. Elashoff, A joint model of longitudinal and competing risks survival data with heterogeneous random effects and outlying longitudinal measurements, Stat Interface 3 (2010), pp. 185–195. doi: 10.4310/SII.2010.v3.n2.a6
   PubMed Web of Science ®Google Scholar
• J.G. Ibrahim, M.H. Chen, and D. Sinha, Bayesian Survival Analysis, Springer-Verlag, New York, 2002.
   Google Scholar
• J.G. Ibrahim, M.H. Chen, and D. Sinha, Bayesian methods for joint modeling of longitudinal and survival data with application to cancer vaccine trials, Statist. Sin. 14 (2004), pp. 863–883.
   Web of Science ®Google Scholar
• N. Lange and L. Ryan, Assessing normality in random effects models, Ann. Stat. 17 (1989), pp. 624–642. doi: 10.1214/aos/1176347130
   Web of Science ®Google Scholar
• A. Lemenuel-Diot, A. Mallet, C. Laveille, and R. Bruno, Estimating heterogeneity in random effects models for longitudinal data, Biometr. J. 47 (2005), pp. 329–345. doi: 10.1002/bimj.200410111
   PubMed Web of Science ®Google Scholar
• G.J. McLachlan and D. Peel, Finite Mixture Models, Wiley, Chichester, 2000.
   Google Scholar
• J.C. Pinheiro and D.M. Bates, Mixed Effects Models in S and S-Plus, Springer-Verlag, New York, 2000.
   Google Scholar
• D. Rizopoulos, JM: An R package for the joint modelling of longitudinal and time-to-event data, J. Statist. Softw 35 (2010), pp. 1–33. doi: 10.18637/jss.v035.i09
   PubMed Web of Science ®Google Scholar
• D. Rizopoulos, G. Verbeke, and G. Molenberghs, Shared parameter models under random effects misspecification, Biometrika 95 (2008), pp. 63–74. doi: 10.1093/biomet/asm087
   Web of Science ®Google Scholar
• I. Sousa, A review on joint modelling of longitudinal measurements and time-to-event, REVSTAT – Statist. J. 9 (2011), pp. 57–81.
   Web of Science ®Google Scholar
• D.J. Spiegelhalter, N.G. Best, B.P. Carlin, and A. van der Linde, Bayesian measures of model complexity and fit, J. R Statist. Soc. Ser. B 64 (2002), pp. 583–639. doi: 10.1111/1467-9868.00353
   Google Scholar
• D.J. Spiegelhalter, A. Thomas, N. Best, and D. Lunn, WinBUGS Examples, MRC Biostatistics Unit, Institute of Public Health and Department of Epidemiology and Public Health, Imperial College School of Medicine, UK, 2003. Available at http://www.mrc-bsu.cam.ac.uk/bugs.
   Google Scholar
• Y.-K. Tseng, F. Hseih, and J.L. Wang, Joint modelling of accelerated failure time and longitudinal data, Biometrika 92 (2005), pp. 587–603. doi: 10.1093/biomet/92.3.587
   Web of Science ®Google Scholar
• A.A. Tsiatis and M. Davidian, Joint modeling of longitudinal and time-to-event data: An overview, Statist. Sin. 14 (2004), pp. 809–834.
   Web of Science ®Google Scholar
• R. Tsonaka, G. Verbeke, and E. Lesaffre, A semi-parameteric shared parameter model to handle nonmonotone non-ignorable missingness, Biometerics, 65 (2009), pp. 81–87. doi: 10.1111/j.1541-0420.2008.01021.x
   PubMed Web of Science ®Google Scholar
• G. Verbeke and E. Lesaffre, A linear mixed-effects model with heterogeneity in the random-effects population, J. Amer. Statist. Assoc. 91 (1996), pp. 217–221. doi: 10.1080/01621459.1996.10476679
   Web of Science ®Google Scholar
• G. Verbeke and G. Molenberghs, Linear Mixed Models for Longitudinal Data, Springer Series in Statistics, Springer-Verlag, New York, 2000.
   Google Scholar
• G. Verbeke and G. Molenberghs, The gradient function as an exploratory goodness-of-fit assessment of the random-effects distribution in mixed models, Biostatistics 14 (2013), pp. 477–490. doi: 10.1093/biostatistics/kxs059
   PubMed Web of Science ®Google Scholar
• S. Viviani, M. Alfo, and D. Rizopoulos, Generalized linear mixed joint model for longitudinal and survival outcomes, Stat. Comput. 24 (2014), pp. 417–427. doi: 10.1007/s11222-013-9378-4
   Web of Science ®Google Scholar
• L. Wu, Mixed Effects Models for Complex Data, Chapman & Hall, Vancouver, 2010.
   Google Scholar
• L. Wu, X. J. Hu, and H. Wu, Joint inference for nonlinear mixed-effects models and time to event at the presence of missing data, Biostatistics 9 (2008), pp. 308–320. doi: 10.1093/biostatistics/kxm029
   PubMed Web of Science ®Google Scholar
• L. Wu, W. Liu, G. Yi, and Y. Huang, Analysis of longitudinal and survival data: Joint modeling, inference methods, and issues, J. Probab. Stat. 2012 (2012), pp. 1–17, Article ID 640153. doi: 10.1155/2012/640153.
   Google Scholar
• W. Xu and D. Hedeker, A random-effects mixture model for classifying treatment response in longitudinal clinical trials, J. Biopharm. Stat. 11 (2001), pp. 253–273. doi: 10.1081/BIP-120008848
   PubMedGoogle Scholar